Platinum Drug Sensitivity Polymorphisms in Stage III Non-small Cell Lung Cancer With Invasion of Mediastinal Lymph Nodes

Conclusion: These polymorphisms contribute to inter-individual sensibility to chemotherapy response. Interrogation of these genetic variations may have potential applicability when deciding the treatment strategy for patients with stage III NSCLC (N2).

Source: Cancer Genomics and Proteomics - August 27, 2020 Category: Cancer & Oncology Authors: NASTASE, A., LUPO, A., LASZLO, V., DAMOTTE, D., DIMA, S., CANNY, E., ALIFANO, M., POPESCU, I., KLEPETKO, W., GRIGOROIU, M. Tags: Experimental Studies Source Type: research